Phase III Failures: What Can Be Done?
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 82
- By:
- Publication type:
- Article
Works matching IS 10648542 AND DT 2005 AND VI 14 AND IP 9
Results: 42
1
2
Calendar of Events.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 80
- Publication type:
- Article
3
2005 DIA BOARD OF DIRECTORS.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 70
- Publication type:
- Article
4
Alliances.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 70
- Publication type:
- Article
5
Company News.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 68
- Publication type:
- Article
6
Mergers/Acquisitions.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 68
- Publication type:
- Article
7
New Offices.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 68
- Publication type:
- Article
8
Finances.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 68
- Publication type:
- Article
9
Awards.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 68
- Publication type:
- Article
10
People News.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 68
- Publication type:
- Article
11
Driving Clinical Trial Innovation.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 66
- By:
- Publication type:
- Article
12
Delivering on the eDiary Promise.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 64
- By:
- Publication type:
- Article
13
A Declaration of Action.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 62
- By:
- Publication type:
- Article
14
Are There Real-World Benefits to the Critical Path Initiative?
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 60
- By:
- Publication type:
- Article
15
Low-Hanging Fruit: A Pilot Project to Standardize Case Report Forms.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 58
- By:
- Publication type:
- Article
16
Leveraging Clinical Trial Technology: Critical to the Initiative's Success.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 56
- By:
- Publication type:
- Article
17
Critical Path Initiative: A Conversation with Janet Woodcock, MD.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 53
- By:
- Publication type:
- Article
18
FDA Compliance Priorities and Evolution.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 48
- By:
- Publication type:
- Article
19
From Study Initiation to Publication-- The Role of Clinical Trial Registers.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 38
- By:
- Publication type:
- Article
20
Have We Pushed Our Pis Too Far?
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 34
- By:
- Publication type:
- Article
21
Patients' Impatience.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 28
- By:
- Publication type:
- Article
22
New Era at FDA.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 24
- Publication type:
- Article
23
Tools for Clinical Trials Professionals.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 22
- Publication type:
- Article
24
CELEBREX UPDATE.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 21
- Publication type:
- Article
25
MEDTRONIC'S DRUG-ELUTING STENT GETS GO-AHEAD IN EU.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 21
- Publication type:
- Article
26
NOT ENOUGH BENEFITS SEEN IN POZEN'S MIGRAINE CANDIDATE, SAY FDA EXPERTS.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 21
- Publication type:
- Article
27
NEW ORPHAN DRUG FOR INFECTIONS IN CYSTIC FIBROSIS PATIENTS.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 21
- Publication type:
- Article
28
NCI INVESTIGATES HORMONE-VACCINE COMBINATION FOR PROSTATE CANCER.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 21
- Publication type:
- Article
29
FEDERAL CIRCUIT REJECTS CHALLENGE TO SARAFEM RULING.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 21
- Publication type:
- Article
30
FDA SAYS NO TO FOREST'S NAMENDA FOR MILD ALZHEIMER'S.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 21
- Publication type:
- Article
31
EFPIA APPLAUDS EU VOTE ON CHILDREN'S MEDICINES.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 20
- Publication type:
- Article
32
FREE DRUG SAMPLES INFLUENCE RESIDENTS' PRESCRIPTIONS.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 20
- Publication type:
- Article
33
FDA ALERTS TO RECALL OF UK COUNTERFEIT LIPITOR.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 20
- Publication type:
- Article
34
Correction.
- Published in:
- 2005
- Publication type:
- Correction Notice
35
Approvals and Filings.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 20
- Publication type:
- Article
36
Fast Track Status.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 20
- Publication type:
- Article
37
Phase I.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 18
- Publication type:
- Article
38
Phase II.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 18
- Publication type:
- Article
39
Phase III.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 18
- Publication type:
- Article
40
Meet the EAB.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 16
- Publication type:
- Article
41
Marketing Drugs to the Public.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 12
- By:
- Publication type:
- Article
42
UPCOMING DIA EVENTS.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 4
- Publication type:
- Article